Literature DB >> 169249

Characteristics of a solubilized thyrotropin receptor from bovine thyroid plasma membranes.

R L Tate, J M Holmes, L D Kohn, R J Winand.   

Abstract

The thyrotropin receptor from bovine thyroid plasma membranes has been solubilized using lithium diiodosalicylate, and an assay to measure thyrotropin binding to the solubilized receptor has been developed. Both the solubilized thyrotropin receptor and the thyrotropin receptor on thyroid plasma membranes have effectively identical nonlinear Scatchard plots and negatively sloped Hill plots, i.e. both preparations have receptors which appear to exhibit a similar negatively cooperative relationship. Although the pH optimum of thyrotropin binding to the solubilized receptor is the same as that of the thyroid plasma membrane receptor, pH 6.0, the pH dependency curve of the solubilized receptor is slightly different in its outline. Thyrotropin binding to the solubilized receptor is less sensitive to salt inhibition than is binding to the thyroid plasma membrane receptor; however, optimal binding remains at 0 degrees. The relative affinities of thyrotropin and two glycoprotein hormones which can be considered structural analogs, luteinizing hormone and human chorionic gonadotropin, are 100:10:5, respectively, toward plasma membrane receptors, but 100:25:40 toward the solubilized receptors. The solubilized receptor preparation is heterogeneous in size in that it has binding components with molecular weights of 286,000, 160,000, 75,000, and 15,000 to 30,000. Tryptic digestion converts all three higher molecular weight components to the 15,000 to 30,000 molecular weight species, and the 15,000 to 30,000 molecular weight receptor component has all of the binding properties of the solubilized receptor preparation before tryptic digestion including an identical nonlinear Scatchard plot. It has the same size as and coelutes from Sephadex G-100 with a 15,000 to 30,000 molecular weight receptor released by tryptic digestion of bovine thyroid plasma membranes or tryptic digestion of bovine or dog thyroid cells in culture. The tryptic fragment of the solubilized receptor or preparations has been purified almost 250-fold by affinity chromatography on thyrotropin-Sepharose columns. The binding activity is lost when the solubilized thyrotropin receptor preparation is exposed to beads of neuraminidase-Sepharose or conconavalin A-Sepharose.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 169249

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Two-subunit structure of the human thyrotropin receptor.

Authors:  H Loosfelt; C Pichon; A Jolivet; M Misrahi; B Caillou; M Jamous; B Vannier; E Milgrom
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

2.  Membrane receptors for hormones and neurotransmitters.

Authors:  C R Kahn
Journal:  J Cell Biol       Date:  1976-08       Impact factor: 10.539

Review 3.  [Cell receptor defects as the cause of endocrine and metabolic diseases (author's transl)].

Authors:  W Gerok
Journal:  Klin Wochenschr       Date:  1979-06-15

Review 4.  The thyrotrophin receptor.

Authors:  S W Manley; A Knight; D D Adams
Journal:  Springer Semin Immunopathol       Date:  1982

5.  Thyrotropin-ganglioside interactions and their relationship to the structure and function of thyrotropin receptors.

Authors:  B R Mullin; P H Fishman; G Lee; S M Aloj; F D Ledley; R J Winand; L D Kohn; R O Brady
Journal:  Proc Natl Acad Sci U S A       Date:  1976-03       Impact factor: 11.205

6.  Alteration in the transmission of TSH-message to thyroid target in a transplantable rat thyroid tumor.

Authors:  P Laccetti; M F Meldolesi; L Beguinot; A Mariano; V Macchia
Journal:  J Endocrinol Invest       Date:  1986-10       Impact factor: 4.256

7.  Monoclonal antibodies to the thyrotropin receptor: stimulating and blocking antibodies derived from the lymphocytes of patients with Graves disease.

Authors:  W A Valente; P Vitti; Z Yavin; E Yavin; C M Rotella; E F Grollman; R S Toccafondi; L D Kohn
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

8.  Monoclonal antibodies to the thyrotropin receptor: the identification of blocking and stimulating antibodies.

Authors:  W A Valente; Z Yavin; E Yavin; E F Grollman; M Schneider; C M Rotella; R Zonefrati; R S Toccafondi; L D Kohn
Journal:  J Endocrinol Invest       Date:  1982 Sep-Oct       Impact factor: 4.256

9.  Separation of two thyrotropin binding components from porcine thyroid tissue by affinity chromatography: characterization of high and low affinity sites.

Authors:  R W Drummond; R McQuade; R Grunwald; C G Thomas; S N Nayfeh
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

10.  Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay.

Authors:  J R Baker; Y G Lukes; R C Smallridge; M Berger; K D Burman
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.